These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1254 related articles for article (PubMed ID: 19455106)
1. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Garcia-Tsao G; Lim JK; Am J Gastroenterol; 2009 Jul; 104(7):1802-29. PubMed ID: 19455106 [TBL] [Abstract][Full Text] [Related]
2. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study. Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340 [TBL] [Abstract][Full Text] [Related]
3. An assessment of the management of acute bleeding varices: a multicenter prospective member-based study. Sorbi D; Gostout CJ; Peura D; Johnson D; Lanza F; Foutch PG; Schleck CD; Zinsmeister AR Am J Gastroenterol; 2003 Nov; 98(11):2424-34. PubMed ID: 14638344 [TBL] [Abstract][Full Text] [Related]
4. Natural history of compensated viral B and D cirrhosis. Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347 [TBL] [Abstract][Full Text] [Related]
5. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Sangiovanni A; Prati GM; Fasani P; Ronchi G; Romeo R; Manini M; Del Ninno E; Morabito A; Colombo M Hepatology; 2006 Jun; 43(6):1303-10. PubMed ID: 16729298 [TBL] [Abstract][Full Text] [Related]
6. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. Planas R; Ballesté B; Alvarez MA; Rivera M; Montoliu S; Galeras JA; Santos J; Coll S; Morillas RM; Solà R J Hepatol; 2004 May; 40(5):823-30. PubMed ID: 15094231 [TBL] [Abstract][Full Text] [Related]
9. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis]. Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023 [TBL] [Abstract][Full Text] [Related]
10. Advances in the treatment of hepatitis C. Lawrence SP Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046 [TBL] [Abstract][Full Text] [Related]
11. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Heidelbaugh JJ; Bruderly M Am Fam Physician; 2006 Sep; 74(5):756-62. PubMed ID: 16970019 [TBL] [Abstract][Full Text] [Related]
12. [Cirrhosis due to hepatitis C virus]. Trinchet JC Rev Prat; 2000 May; 50(10):1094-9. PubMed ID: 10905095 [TBL] [Abstract][Full Text] [Related]
13. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications]. Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817 [TBL] [Abstract][Full Text] [Related]
14. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Grace ND Am J Gastroenterol; 1997 Jul; 92(7):1081-91. PubMed ID: 9219775 [TBL] [Abstract][Full Text] [Related]
16. [Surgical approach to posthepatitic cirrhotic patient today]. Meriggi F; Forni E G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983 [TBL] [Abstract][Full Text] [Related]
17. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score. Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510 [TBL] [Abstract][Full Text] [Related]
18. Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients. Solà R; Alvarez MA; Ballesté B; Montoliu S; Rivera M; Miquel M; Cirera I; Morillas RM; Coll S; Planas R Liver Int; 2006 Feb; 26(1):62-72. PubMed ID: 16420511 [TBL] [Abstract][Full Text] [Related]
19. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office. ; Yee HS; Currie SL; Darling JM; Wright TL Am J Gastroenterol; 2006 Oct; 101(10):2360-78. PubMed ID: 17032203 [TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis. Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]